Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
insulin
Pharma
With strong data, Lilly plots filings for weekly insulin asset
With detailed readouts from a suite of late-stage trials, Eli Lilly is heading to regulators with its once-a-week insulin asset efsitora alfa.
Fraiser Kansteiner
Jun 23, 2025 10:16am
Schott Pharma invests €100M in Hungary manufacturing expansion
Jun 5, 2025 9:40am
Sanofi gains FDA nod for first biosimilar version of NovoLog
Feb 18, 2025 11:05am
Novo Nordisk to slash prices of Fiasp, Tresiba in 2026
Dec 6, 2024 11:44am
Sanofi blueprints €1B insulin production hub in Beijing
Dec 2, 2024 10:50am
Novo to gradually phase out production of human insulin pens
Nov 14, 2024 2:13pm
